Moreover, an increase in soluble ACE2 levels has been detected in patients with cardiovascular and inflammatory conditions, in those with COVID-19 and in the aging population, indicating convergence to the ACE2–renin–angiotensin system (Batlle et al., 2022; Verdecchia et al., 2020). Here, ACE2 is linked to COVID-19.